The virus may have moved on, but its effects are still unfolding
Long after the fevers broke and the isolation ended, SARS-CoV-2 appears to have left a quieter disruption behind — one that unfolds in the dark, breath by interrupted breath. A study of nearly a million adults found that COVID-19 infection raised the risk of developing obstructive sleep apnea by a third to nearly half, a vulnerability that persisted for years regardless of whether patients had been hospitalized. In the long arc of this pandemic's consequences, the body's nightly struggle to breathe may prove to be among its most enduring and underrecognized legacies.
- A study of 910,000 adults reveals that COVID-19 infection raises the risk of obstructive sleep apnea by 33–41% — and that elevated risk holds for years after recovery.
- The danger is not confined to the severely ill: even patients who recovered at home without hospitalization faced significantly higher odds of developing the condition.
- For those who were hospitalized and later developed sleep apnea, the stakes climbed further — with elevated rates of pulmonary hypertension and heart failure signaling deeper systemic damage.
- The risk falls unevenly: Black patients, younger adults, women, and Hispanic individuals showed particularly strong associations, pointing to populations most in need of targeted screening.
- Clinicians are being urged to ask post-COVID patients about sleep symptoms — snoring, daytime fatigue, morning headaches — and refer early, before years of oxygen deprivation compound into cardiac and cognitive harm.
Nearly a million adults have now provided evidence of something that outlasted the acute phase of COVID-19: a persistent vulnerability to sleep apnea. Researchers analyzing electronic health records from a large urban hospital system found that people who tested positive for SARS-CoV-2 faced a measurably higher risk of developing obstructive sleep apnea — a condition in which the throat repeatedly collapses during sleep — up to four and a half years after infection. The finding held whether patients had been hospitalized or had recovered at home.
Among hospitalized COVID patients, the adjusted risk of new sleep apnea was 41 percent higher than in uninfected individuals; among those who recovered without hospital care, it was 33 percent higher. Researchers controlled for age, race, income, insurance status, vaccination history, and existing conditions — standard adjustments meant to isolate the COVID effect from other explanations.
The consequences of untreated sleep apnea are serious and cumulative: high blood pressure, irregular heartbeat, stroke, diabetes, and cognitive decline. Among COVID patients who developed the condition, those who had been hospitalized also showed elevated rates of pulmonary hypertension and heart failure, suggesting the virus left lasting marks on respiratory and cardiac systems.
The biological mechanism remains uncertain. COVID-19 is known to trigger persistent inflammation, disrupt the autonomic nervous system, and affect the central nervous system — any of which could alter how the body manages breathing during sleep. The study's authors acknowledged a key limitation: they relied on diagnostic codes in electronic health records rather than objective sleep studies, so association rather than causation is what the data can establish.
Risk was not evenly distributed. Hospitalized Black patients, adults under 60, and those with asthma showed particularly strong associations. Among non-hospitalized patients, women, Hispanic individuals, and those with significant existing conditions bore higher risk. Vaccination status did not meaningfully alter outcomes in any group.
The clinical message is sharpening: physicians caring for post-COVID patients — especially those who were hospitalized — should now routinely ask about sleep symptoms and refer early for evaluation. The virus that reshaped so many lives continues, for many, to reshape the body one night at a time.
Nearly a million adults have now provided evidence of something that lingered long after the acute phase of COVID-19 passed: a persistent vulnerability to sleep apnea. Researchers analyzing electronic health records from a large urban hospital system found that people who had tested positive for SARS-CoV-2 faced a measurably higher risk of developing obstructive sleep apnea—a condition in which the throat repeatedly collapses during sleep—up to four and a half years after their initial infection. The finding held true whether patients had been sick enough to require hospitalization or had recovered at home.
The study examined 910,000 adults who underwent testing between March 2020 and August 2024. Researchers divided them into three groups: those hospitalized with COVID-19, those who tested positive but never needed hospital care, and those who tested negative. Among the hospitalized group, the adjusted risk of developing new sleep apnea was 41 percent higher than in the uninfected population. For those who recovered without hospitalization, the risk climbed 33 percent higher. These were not trivial margins. The researchers controlled for age, race, ethnicity, income, insurance status, vaccination history, and existing medical conditions—the standard adjustments meant to isolate the COVID effect from other variables that might explain the difference.
Obstructive sleep apnea is not a minor inconvenience. When the airway collapses repeatedly through the night, the brain and body experience fragmented sleep and intermittent oxygen deprivation. Left untreated, the condition increases the risk of high blood pressure, irregular heartbeat, stroke, diabetes, and cognitive decline. It is the kind of disorder that compounds over time, wearing on the cardiovascular system night after night. Among the COVID patients in this study who went on to develop sleep apnea, those who had been hospitalized faced an additional burden: they showed higher rates of pulmonary hypertension and heart failure, suggesting that the virus had left deeper marks on their respiratory and cardiac systems.
The mechanism remains uncertain. Researchers know that COVID-19 triggers persistent inflammation throughout the body, disrupts the autonomic nervous system—the network that controls involuntary functions like breathing—and can involve the central nervous system directly. Any or all of these effects could alter how the body manages breathing during sleep. But this study, based on diagnostic codes in electronic health records rather than objective sleep testing, can only demonstrate association, not prove that the virus caused the apnea. The researchers themselves flagged this limitation: they relied on ICD-10 diagnostic codes rather than polysomnography, the gold standard sleep study that directly measures airway collapse and oxygen levels.
The risk was not evenly distributed across demographic groups. Among hospitalized patients, Black individuals, people under 60, and those with asthma showed particularly strong associations with new sleep apnea. Among non-hospitalized patients, women, Hispanic individuals, and those with significant existing medical conditions bore higher risk. These subgroup findings, the authors cautioned, were not adjusted for confounding factors and should be interpreted carefully. Vaccination status did not meaningfully alter the risk in any group.
The implications for clinical practice are becoming clearer. Doctors treating patients with a history of COVID-19—particularly those who were hospitalized—should now ask about sleep apnea symptoms: loud snoring, witnessed breathing pauses, daytime sleepiness, morning headaches. If symptoms emerge, early referral for sleep testing and treatment could prevent years of accumulated damage to the heart and brain. The study validates what some clinicians have already begun to suspect: that COVID-19's reach extends into the sleeping hours, and that vigilance in the years after infection may prevent serious downstream complications.
Future research will need to move beyond diagnostic codes to objective sleep assessments and explore the biological pathways linking viral infection to airway collapse. Until then, this large observational study offers a clear signal: the virus that disrupted so many lives in 2020 and beyond continues to reshape the bodies of those it infected, one breath at a time.
Citações Notáveis
Clinicians should consider targeted screening for sleep apnea symptoms in higher-risk people with a prior COVID-19 history, with early diagnostic referral and treatment strategies if symptoms are detected— Study findings from Scientific Reports
A Conversa do Hearth Outra perspectiva sobre a história
Why does COVID-19 seem to affect sleep breathing specifically? Couldn't it just be that sick people develop more health problems in general?
That's a fair question, and the researchers tried to account for it. They adjusted for existing conditions, age, race, income—all the things that predict worse health outcomes. Even after removing those factors, COVID-positive people still had a 33 to 41 percent higher risk. So it's not just that they were already sick. Something about the infection itself appears to alter how the body manages breathing during sleep.
But the study used diagnostic codes, not actual sleep tests. Couldn't doctors just be diagnosing sleep apnea more often in COVID patients because they're looking for it?
That's a real limitation the authors acknowledged. Detection bias is possible—if you've had COVID and you mention being tired, your doctor might order a sleep study where they wouldn't have before. But they also validated the findings using a historical control group from 2016 to 2019, before COVID existed. The pattern held. So while detection bias may play a role, it doesn't fully explain the signal.
Who's at highest risk? Should everyone who had COVID be screened?
The data suggests certain groups warrant closer attention: people who were hospitalized, younger patients, racial and ethnic minorities, and those with conditions like asthma. But honestly, the safest approach is probably to ask all post-COVID patients about sleep apnea symptoms—snoring, gasping awake, daytime exhaustion. If those are present, get objective testing. You don't need to screen everyone, but you need to listen.
What happens if sleep apnea goes undiagnosed in a COVID survivor?
Night after night of oxygen drops and fragmented sleep. Over months and years, that stresses the heart, raises blood pressure, increases stroke risk. In this study, hospitalized COVID patients who developed sleep apnea also developed pulmonary hypertension and heart failure at higher rates. It's not just about poor sleep quality—it's about cumulative cardiovascular damage.
So what should change in how doctors treat post-COVID patients?
Vigilance. Ask about sleep symptoms. If someone has them, don't wait. Get them a sleep study. Early treatment—whether that's a CPAP machine or other interventions—can prevent years of damage. The virus may have moved on, but its effects are still unfolding in the bodies of millions of people.